Contributions
2,941 recent contributions in Hansard
HANSARDCannabis OilI thank the noble Lord for sharing that personal testimony, which is extremely touching and relevant. I share with him that there is a large amount of ministerial support for the…12 Jan 2021HANSARDCannabis OilThe noble Baroness puts a very reasonable challenge to the life sciences arrangements in the UK. We are blessed with major pharmaceutical companies, and a lively and exciting…12 Jan 2021HANSARDCannabis OilThe noble Lord alludes to an important, although frustrating, point. If I may gently push back, the truth is that there is a large amount of very persuasive anecdotal evidence,…12 Jan 2021HANSARDCannabis OilMy Lords, procurement decisions in the NHS are done by the NHS. I do not think that a specific or unique group is focused precisely on hormone therapies, but I would be glad to go…12 Jan 2021HANSARDCannabis OilMy Lords, the noble Baroness is being a little unfair; Health Education England published a medicinal cannabis education package on 8 August 2019. But we cannot force clinicians…12 Jan 2021HANSARDCannabis OilMy Lords, we are on the case. I completely recognise the problems faced by Alfie Dingley and all the individuals reliant on the previous arrangements with the Dutch Government for…12 Jan 2021HANSARDCannabis OilMy Lords, I am grateful for the noble Baroness’s kind words, and I will indeed take that patient feedback back to the department. I reassure her that this is an area where…12 Jan 2021HANSARDMedicines and Medical Devices BillMy Lords, one of the key qualities of this place is bringing to bear years of expertise in refining legislation. From those involved in life sciences to ex-Health Ministers, we…12 Jan 2021HANSARDMedicines and Medical Devices BillMy Lords, I am enormously grateful for that helpful debate. Let me try to provide some of the clarity and reassurances noble Lords have sought. Amendment 14 to Clause 3 would add…12 Jan 2021HANSARDMedicines and Medical Devices Bill12 Jan 2021HANSARDCovid-19: VaccineI think the noble Lord has read too much into the AstraZeneca statement. Negotiations with AstraZeneca and provisions in manufacturing capacity are extremely well advanced. All…12 Jan 2021HANSARDMedicines and Medical Devices Bill12 Jan 2021HANSARDCovid-19: VaccineThe central proposition we are discussing is that it is better to double the number of people getting their first jab, even if there is a marginal decrease in the efficacy of the…12 Jan 2021HANSARDMedicines and Medical Devices Bill12 Jan 2021HANSARDCovid-19: VaccineThe noble Lord alludes to a complicated dilemma that we all feel. I welcome challenge and those who query and question the basis of our policy decisions and our science. He is…12 Jan 2021HANSARDCovid-19: VaccineThe CMO has made it clear that he leans heavily towards having consistent vaccines, but it is not a requirement. Some of the immune response comes from antibodies which can be…12 Jan 2021HANSARDCovid-19: VaccineThe noble Baroness is right; this virus could mutate and start escaping the vaccine. That is a very real threat. The good news is that we know so much about it now, have digitally…12 Jan 2021HANSARDMedicines and Medical Devices BillMy Lords, patient safety is very much at the heart of the Bill, and while we have an enormous amount to get through this afternoon, I beg the Chamber’s forbearance if I talk in…12 Jan 2021HANSARDCovid-19: VaccineThe noble Baroness is right that communication is key. We seek to explain the scientific basis of this vaccine, and a huge amount of effort has gone into what I call “O-level…12 Jan 2021HANSARDMedicines and Medical Devices BillMy Lords, I will save my Hollywood thank-yous for the end of the process, but profound thanks will need to be said. I want to say specific thanks to those who have spoken in the…12 Jan 2021